Skip to main content
. 2016 Oct 27;7(47):78110–78118. doi: 10.18632/oncotarget.12948

Table 2. Genotype and allele frequencies of FEN1 polymorphisms among the cases and controls and the associations with BC risk.

Model Genotype Case(560) Control(583) OR (95% CI) P-value*
rs4246215
Codominant G/G 260 (46.4%) 245 (42.0%) 1.00 (reference) 0.026
G/T 249 (44.5%) 256 (43.9%) 0.92 (0.72-1.17) 0.49
T/T 51 (9.1%) 82 (14.1%) 0.59 (0.40-0.87) 0.007
Dominant GG 260 (46.4%) 265 (43.9%) 1.00 (reference)
G/T-T/T 300 (53.6%) 338 (56.1%) 0.84 (0.66-1.06) 0.13
Recessive G/G-C/T 509 (90.9%) 501 (85.9%) 1.00 (reference)
T/T 51 (9.1%) 82 (14.1%) 0.61 (0.42-0.89) 0.009
Overdominant G/G-C/T 311 (55.5%) 327 (56.1%) 1.00 (reference)
G/T 249 (44.5%) 256 (43.9%) 1.02 (0.81-1.29) 0.85
Allele G 769 (68.7%) 746 (64.0%) 1.00 (reference)
T 351 (31.3%) 420 (36.0%) 0.81 (0.68-0.96) 0.018
rs174538
Codominant G/G 243 (43.4%) 233 (40.0%) 1.00 (reference) 0.32
G/A 256 (45.7%) 272 (46.6%) 0.90 (0.70-1.16) 0.42
A/A 61 (10.9%) 78 (13.4%) 0.75 (0.51-1.10) 0.14
Dominant G/G 243 (43.4%) 233 (40.0%) 1.00 (reference)
G/A-A/A 317 (56.6%) 350 (60.0%) 0.87 (0.69-1.10) 0.24
Recessive G/G-G/AG 499 (89.1%) 505 (86.6%) 1.00 (reference)
A/A 61 (10.9%) 78 (13.4%) 0.79 (0.55-1.13) 0.20
Overdominant G/G-G/AG 294 (53.5%) 311 (53.3%) 1.00 (reference)
A/A 256 (46.5%) 272 (46.7%) 0.96 (0.76-1.22) 0.75
Allele C 742 (66.3%) 738 (63.3%) 1.00 (reference)
T 378 (33.7%) 428 (36.7%) 0.88 (0.74-1.04) 0.14
*

Two-sided χ2 test for the distributions of genotype and allele frequencies.

Adjusted for age and body mass index.